Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kymera Therapeutics (KYMR) Assets Average (2020 - 2025)

Kymera Therapeutics (KYMR) has disclosed Assets Average for 6 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • Quarterly Assets Average rose 41.33% to $1.4 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.4 billion through Dec 2025, up 41.33% year-over-year, with the annual reading at $1.4 billion for FY2025, 75.11% up from the prior year.
  • Assets Average for Q4 2025 was $1.4 billion at Kymera Therapeutics, up from $1.1 billion in the prior quarter.
  • The five-year high for Assets Average was $1.4 billion in Q4 2025, with the low at $449.5 million in Q2 2021.
  • Average Assets Average over 5 years is $738.6 million, with a median of $614.7 million recorded in 2022.
  • The sharpest move saw Assets Average fell 9.14% in 2023, then soared 78.42% in 2024.
  • Over 5 years, Assets Average stood at $624.2 million in 2021, then dropped by 0.54% to $620.8 million in 2022, then fell by 9.14% to $564.1 million in 2023, then skyrocketed by 78.42% to $1.0 billion in 2024, then skyrocketed by 41.33% to $1.4 billion in 2025.
  • According to Business Quant data, Assets Average over the past three periods came in at $1.4 billion, $1.1 billion, and $1.0 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.